Osamu Kanazawa
Directeur/Membre du Conseil chez Neuroceuticals, Inc.
Profil
Osamu Kanazawa is currently the Director & Vice President at Neuroceuticals, Inc. He previously worked as a Director at Glycoscience Laboratories, Inc.
Postes actifs de Osamu Kanazawa
| Sociétés | Poste | Début |
|---|---|---|
Neuroceuticals, Inc.
 Neuroceuticals, Inc. Medical SpecialtiesHealth Technology Neuroceuticals, Inc. is a Japanese medical device development venture company founded in 2009. The company is based in Tokyo, Japan. The company focuses on exploring the needs of doctors through their unique marketing network to develop products that enable more efficient diagnosis and treatment, as well as improve the quality of life for patients. | Directeur/Membre du Conseil | 01/01/2016 |
Anciens postes connus de Osamu Kanazawa
| Sociétés | Poste | Fin |
|---|---|---|
Glycoscience Laboratories, Inc.
 Glycoscience Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Glycoscience Laboratories, Inc. operates as a holding company that engages in the research and development of medical technologies. The firm also develops glycomedicines, with a focus on finding medical applications for glycosaminoglycans. It provides medical research on proteins, nucleic acids, and carbohydrates. The firm’s business activities include drug discovery, basic cosmetics development, and health food and supplements production. The company was founded by Akira Asari on April 15, 2005 and is headquartered in Tokyo, Japan. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Glycoscience Laboratories, Inc.
Glycoscience Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Glycoscience Laboratories, Inc. operates as a holding company that engages in the research and development of medical technologies. The firm also develops glycomedicines, with a focus on finding medical applications for glycosaminoglycans. It provides medical research on proteins, nucleic acids, and carbohydrates. The firm’s business activities include drug discovery, basic cosmetics development, and health food and supplements production. The company was founded by Akira Asari on April 15, 2005 and is headquartered in Tokyo, Japan. | Commercial Services |
Neuroceuticals, Inc.
Neuroceuticals, Inc. Medical SpecialtiesHealth Technology Neuroceuticals, Inc. is a Japanese medical device development venture company founded in 2009. The company is based in Tokyo, Japan. The company focuses on exploring the needs of doctors through their unique marketing network to develop products that enable more efficient diagnosis and treatment, as well as improve the quality of life for patients. | Health Technology |
